High sensitivity of diffusion-weighted mr imaging for the detection of liver metastases from neuroendocrine tumors : Comparison with t2-weighted and dynamic gadolinium-enhanced mr imaging

Radiology

Volumn 268, Issue 2, 2013, Pages 390-399

  d'Assignies, Gaspard ^a,e   Fina, Priscilla ^a   Bruno, Onorina ^a   Vullierme, Marie Pierre ^a   Tubach, Florence ^f   Paradis, Valérie ^b,e   Sauvanet, Alain ^c   Ruszniewski, Philippe ^d,e   Vilgrain, Valérie ^a,e  

^a Departments of Radiology   (France)

^b Pathology ^*  (France)

^c Hepatobiliary Surgery   (France)

^d BEAUJON HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PEROPERATIVE ECHOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOPSY; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HEPATECTOMY; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; NEUROENDOCRINE TUMORS; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84880677151     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13121628     Document Type: Article

References (22)

1. Norton JA. Endocrine tumours of the gastrointestinal tract: Surgical treatment of neuroendocrine metastases. Best Pract Res Clin Gastroenterol 2005;19(4):577-583.
2. Tomassetti P, Campana D, Piscitelli L, et al. Endocrine pancreatic tumors: Factors correlated with survival. Ann Oncol 2005; 16(11):1806-1810.
3. Oberg K, Astrup L, Eriksson B, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part II. Specific NE tumour types. Acta Oncol 2004;43(7):626-636.
4. Akerström G, Falconi M, Kianmanesh R, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre-and perioperative therapy in patients with neuroendocrine tumors. Neuroendocrinology 2009;90(2):203-208.
5. Dromain C, de Baere T, Baudin E, et al. MR imaging of hepatic metastases caused by neuroendocrine tumors: Comparing four techniques. AJR Am J Roentgenol 2003;180(1):121-128.
6. Dromain C, de Baere T, Lumbroso J, et al. Detection of liver metastases from endocrine tumors: A prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 2005;23(1):70-78.
7. Elias D, Lefevre JH, Duvillard P, et al. Hepatic metastases from neuroendocrine tumors with a "thin slice" pathological examination: They are many more than you think. Ann Surg 2010;251(2):307-310.
8. Coenegrachts K, Delanote J, Ter Beek L, et al. Improved focal liver lesion detection: Comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007;80(955):524-531.
9. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: Diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 2006;239(1):122-130.
10. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging: Comparison with standard breath-hold T2-weighted imaging. Radiology 2008;246(3):812-822.
11. Soyer P, Boudiaf M, Place V, et al. Preoperative detection of hepatic metastases: Comparison of diffusion-weighted, T2-weighted fast spin echo and gadolinium-enhanced MR imaging using surgical and histopathologic findings as standard of reference. Eur J Radiol 2011;80(2):245-252.
12. Zech CJ, Herrmann KA, Dietrich O, Horger W, Reiser MF, Schoenberg SO. Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: Comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol 2008;43(4):261-266.
13. Bruegel M, Gaa J, Waldt S, et al. Diagnosis of hepatic metastasis: Comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol 2008;191(5):1421- 1429.
14. Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: Value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 2007;25(4):848-858.
15. Hardie AD, Naik M, Hecht EM, et al. Diagnosis of liver metastases: Value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol 2010;20(6):1431-1441.
16. Koh DM, Collins DJ, Wallace T, Chau I, Riddell AM. Combining diffusion-weighted MRI with Gd-EOB-DTPA-enhanced MRI improves the detection of colorectal liver metastases. Br J Radiol 2012;85(1015):980-989.
17. Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 2010;20(11):2690-2698.
18. Semelka RC, Brown ED, Ascher SM, et al. Hepatic hemangiomas: A multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology 1994;192(2):401-406.
19. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
20. Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology 2010;254(1): 47-66.
21. Erturk SM, Ichikawa T, Sano K, Motosugi U, Sou H, Araki T. Diffusion-weighted magnetic resonance imaging for characterization of focal liver masses: Impact of parallel imaging (SENSE) and b value. J Comput Assist Tomogr 2008;32(6):865-871.
22. Padhani AR, Liu G, Koh DM, et al. Diffusionweighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations. Neoplasia 2009;11(2):102-125.